Navigation Links
Studies Show Pterostilbene Shows Promise for Anti-Aging and Maintaining Healthy Brain
Date:1/9/2014

Houston, TX (PRWEB) January 09, 2014

With 1 in 3 seniors dying with Alzheimer’s or another dementia (source), scientists have long been fighting to find a way to preserve brain health as we age. Now, hope comes from a little-known compound found in blueberries called pterostilbene. In clinical studies, pterostilbene has shown promise as a treatment in the protection against age-related diseases, including Alzheimer’s disease.
In the September 2012 study published first in Neurobiology of Aging, researchers looked at mice that were genetically developed as a model of age-related cognitive decline. The mice were give two different compounds containing pterostilbene and resveratrol. The study found that pterostilbene was the most effective at positively affecting brain function. Now, researchers see hope that pterostilbene could offer the same brain-boosting benefits in humans.
The researchers said, “While it is yet to be determined whether the cognitive improvements induced by pterostilbene in the SAMP8 model can be applied to humans, recent reports demonstrate that fruits containing pterostilbene such as blueberries ameliorate cognitive function in aged humans.”

With so many positive cognitive enhancement benefits associated with pterostilbene, it’s no wonder many people are searching for ways to add more of this potent compound to their diet. It was even named one of the best nootropics by NootropicStack.net. A new memory enhancement supplement, Biohack Pure, features pterostilbene as a key ingredient.

“Based on all the research we’ve seen, pterostilbene is a highly effective antioxidant that fights free radicals and plays a key role in cognitive enhancement,” said Jonathan Weisman, president at Biohack Nutrition, makers of Biohack Pure. “We’re really excited for the potential of this berry compound at helping preserve brain health and preventing cognitive decline.”
For more information, visit http://www.BiohackPure.com.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11473898.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. S*BIOs Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF)
2. Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease
3. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
4. Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus
5. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
6. Novel compound halts tumor spread, improves brain cancer treatment in animal studies
7. Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain
8. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
9. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
10. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
11. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and ... premier sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global ... new agreement with Bankok,Thailand-based Global Stem Cells Network (GSCN) to distribute exosome injection ... American countries, including Mexico, Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El ...
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... , Feb. 10, 2016  Matchbook, Inc., a ... fast growing biotech companies, announced today the appointment ... Strategic Advisor. Jim brings nearly 25 years of ... procurement, having spent nearly two decades in executive ... and Procurement at Genzyme and, most recently headed ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
(Date:2/1/2016)... 2016 Rising sales of consumer ... touchfree intuitive gesture control market size ... of consumer electronics coupled with new technological advancements to ... size through 2020   --> ... technological advancements to drive global touchfree intuitive gesture control ...
(Date:1/28/2016)... 28, 2016 Synaptics (NASDAQ: SYNA ), a leading ... second quarter ended December 31, 2015. --> ... fiscal 2016 increased 2 percent compared to the comparable quarter last ... fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... for the first quarter of fiscal 2016 grew 9 percent over ...
Breaking Biology News(10 mins):